OXFORD TEXTBOOK OF NEURO-ONCOLOGY

1: The 2016 revision of the WHO classification of tumours of the central nervous system,
2: Astrocytoma subtypes of children and adults: Pilocytic astrocytoma, pleomorphic xantoastrocytoma, and subependymal giant cell astrocytoma,
3: Diffuse astrocytoma, anaplastic astrocytoma, glioblastoma, and gliomatosis cerebri,
4: Oligodendroglial tumours,
5: Ependymal tumours,
6: Choroid plexus tumours,
7: Astroblastoma, angiocentric glioma, and chordoid glioma,
8: Neuronal and mixed neuronal-glial tumours,
9: Embryonal and pineal tumours,
10: Tumours of the cranial nerves,
11: Management of meningiomas,
12: Other tumours of the meninges,
13: Lymphomas and hematopoietic neoplasms,
14: Germ cell tumours,
15: Familial tumour syndromes-A,
16: Familial tumour syndromes-B (von Hippel-Lindau disease),
17: Tuberous sclerosis complex,
18: The multidisciplinary management of pituitary disorders,
19: Metastatic brain tumours,
20: Metastatic tumours - Spinal cord, plexus, peripheral nerve,
21: Neoplastic meningitis: Metastases to the leptomeninges and cerebrospinal fluid,

Part of the Oxford Textbooks in Clinical Neurology series, the Oxford Textbook of Neuro-Oncology covers the pathophysiology, diagnosis, classification, and management of tumours of the nervous system. The book provides a comprehensive overview of tumour subtypes, in accordance with WHO classifications, along with management plans for adult and paediatric populations. The international team of co-editors ensures that expert commentaries on existing and wide-reaching diagnostic and treatment guidelines (including NCCN and ESMO) are accessible by a global audience.

Features
• A globally relevant and comprehensive text with an easy-to-update online version in order to keep pace with new developments in this rapidly changing field.
• Written by an international team of co-editors, with chapters arranged in accordance with the widely accepted WHO classification of tumour subtypes.
• A comprehensive overview of each of the tumour subtypes, with management plans for both adult and paediatric populations.

Authors
• Tracy Batchelor, Giovanni Armenise-Harvard Professor of Neurology, Harvard Medical School, Boston, MA, USA.
• Ryo Nishikawa, Professor and Chair, Department of Neuro-Oncology, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan.
• Nancy Tarbell, CC Wang Professor of Radiation Oncology, Harvard Medical School, Boston, MA, USA.
• Michael Weller, Professor and Chairman, Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland